ABSTRACT
The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study evaluated feasible treatment strategies to improve clinical outcomes for real-world patients with treatment-resistant depression. Although the study found no clear-cut “winner,” it does provide guidance on how to start therapy and how to proceed if initial treatment fails.
Footnotes
↵* The authors’ disclosures of potential conflicts of interest are listed at the end of this paper.
- Copyright © 2008 The Cleveland Clinic Foundation. All Rights Reserved.
Jump to section
Related Articles
Cited By...
- EEG-Based Prediction of rTMS Treatment Response in Depression: Nonlinear Features and Machine Learning with Minimal Electrode
- Restoring STAR*D: A RIAT Reanalysis of Medication Augmentation Therapy After Failed SSRI Treatment Using Patient-Level Data with Fidelity to the Original Research Protocol
- Why the irremediability requirement is not sufficient to deny psychiatric euthanasia for patients with treatment-resistant depression
- The role of IL-6 in dopamine dysregulation underlying anhedonia phenotype in rats
- Effect of Insomnia on Repetitive Transcranial Magnetic Stimulation Treatment Outcomes for Depression
- Neutrophil-lymphocyte ratio across psychiatric diagnoses: An electronic health record investigation
- Neutrophil-lymphocyte ratio across psychiatric diagnoses: a cross-sectional study using electronic health records
- STAR*D: A Tale and Trail of Bias
- Are all antidepressants equal?